22 May 2013
Keywords: taxotere, effective, breast, cancer, results, multicenter, phase
Article | 17 October 1994
The results of two multicenter Phase II trials carried out in the USA have shown that Rhone-Poulenc Rorer's Taxotere (docetaxel) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.